Equity Research
In this interview with the Boston affiliate of NPR – WBUR – research analyst Myles Minter shares his insights on the long-term value, if any, of one COVID-19 vaccine producer, in this case Moderna, being first to market with an approved vaccine for children under the age of five.
Stay up-to-date with the latest William Blair news and insights
William Blair acted as the exclusive financial advisor to Nothum Food Processing Solutions in connection with its sale to Fortifi Food Processing Solutions, a KKR portfolio company.
Read moreWilliam Blair initiated research coverage of On Holding AG (ONON $32.87), a fast-growing performance and lifestyle brand based in Switzerland selling athletic footwear, primarily in running, but with a growing presence in newer categories and apparel.
Read moreIn addition to retirement considerations, any employee preparing to leave a job should plan for life after employee benefits.
Read moreInformation contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.
For disclosure information, please visit www.williamblair.com/disclosures
